Press Releases Sensus Healthcare, Inc.

Equities

SRTS

US81728J1097

Real-time Estimate Cboe BZX Other stock markets 09:30:09 2024-04-30 am EDT			5-day change	1st Jan Change
3.42 ^USD	+0.88%		0.00%	+43.64%

Feb. 08	Transcript : Sensus Healthcare, Inc., Q4 2023 Earnings Call, Feb 08, 2024
Feb. 08	Sensus Healthcare, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024	Apr. 25	GL
Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024	Apr. 25	AQ
Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024	Apr. 18	GL
Sensus Healthcare to Participate in the 36th Annual Roth Conference	Mar. 14	GL
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting	Mar. 13	GL
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting	Mar. 13	AQ
Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results	Feb. 08	AQ
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities	Feb. 08	GL
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities	Feb. 08	AQ
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements	Feb. 06	GL
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements	Feb. 06	AQ
Sensus Healthcare Announces Retirement of Director Samuel O’Rear	Feb. 01	GL
Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024	Jan. 30	GL
Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024	Jan. 30	AQ
Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million	Jan. 23	GL
Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million	Jan. 23	AQ
Sensus Healthcare Reports Third Quarter 2023 Financial Results	Nov. 09	AQ
Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023	Nov. 02	GL
Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023	Nov. 02	AQ
Sensus Healthcare to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference	23-10-09	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Sensus Healthcare, Inc.

Equities

SRTS

US81728J1097

Press Releases

Filters